Retraction: Enhancer RNA SLIT2 inhibits bone metastasis of breast cancer through regulating P38 MAPK/c-Fos signaling pathway May 7, 2026 0 min Frontiers In Oncology Share Summary Takeaways Listen Quiz 1 The article on enhancer RNA SLIT2's role in breast cancer bone metastasis has been retracted due to image integrity concerns. 2 Image duplication issues were identified in Figures 8 and 9, leading to questions about the reliability of the data. 3 The authors did not provide a satisfactory explanation during the investigation, resulting in the article's retraction. 4 The retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor. 5 This retraction acknowledges the concerns raised by Sholto David regarding the integrity of the published article.